In this video, Rod discusses delta-8 THC, CBD and cannabis in Europe and Mexico, the role of international treaties in cannabis reform, California’s Proposition 65, and the FDA’s position on CBD, among other cannabis issues.
Category: Marijuana / Cannabis
UN Holds Historic Cannabis Vote
A UN committee voted today on six proposals regarding cannabis. In addition to voting to remove cannabis from schedule IV, the Committee voted on five other related proposals.
Watch Rod on the Cannabinoid Connect Podcast (Video)
I recently had a wide-ranging discussion about cannabinoids, hemp, and marijuana with Kevin Carrillo of the Cannabinoid Connect podcast. Watch it here.
Medical Cannabis and Workers’ Compensation
Workers’ compensation cases are likely to continue highlighting the tension between federal and state cannabis laws.
Talking Cannabis (Podcast)
I recently had an in depth discussion with Maynard Breslow of Dank Discussions Podcast. We discussed a number of important topics currently facing the cannabis industry.
Medical Cannabis Clinical Evidence Is Becoming Immune To State Borders
A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
Cannabis Impairment and Driving: Legal and Medical Considerations
The notion that impairment can be assumed or not based solely on specific concentrations of THC or its metabolites in a driver’s blood or urine is plainly wrong.
Want to Read the Latest Edition of the American Journal of Endocannabinoid Medicine?
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
Are Oregon Cannabis Dispensaries Offering an Essential Service?
If cannabis stores close, the state of Oregon would be depriving many patients who rely on retail cannabis stores access to their medicine. If retail cannabis stores remain open, does it make sense to limit access to medicinal patents?